Zymeworks Inc. Common Stock (ZYME) — Cash Flow Reinvestment Rate
Zymeworks Inc. Common Stock (ZYME) has a Cash Flow Reinvestment Rate of 0.80x as of June 2025, reinvesting $9.63 Million (capex $884.00K plus investments $8.74 Million) from operating cash flow of $12.07 Million. Explore ZYME capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zymeworks Inc. Common Stock Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Zymeworks Inc. Common Stock across 3 annual periods. Also explore ZYME total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zymeworks Inc. Common Stock (2017–2022)
Year-by-year capital reinvestment analysis for Zymeworks Inc. Common Stock. For live market cap and broader valuation context, see how much is Zymeworks Inc. Common Stock worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.46x | $66.97 Million | $144.11 Million | $13.12 Million | ▼ -89.7% |
| 2018 | 4.51x | $109.05 Million | $24.18 Million | $3.42 Million | ▼ -96.8% |
| 2017 | 141.04x | $30.89 Million | $219.00K | $3.12 Million | — |